Favre R - Search Results

1

[Pharmacokinetics in phase IV studies for the preview of a therapeutic protocol].

Favre R, Charbit M, Rinaldi Y, Iliadis A, Cano JP, Carcassonne Y. Favre R, et al. Bull Cancer. 1988;75(6):541-50. Bull Cancer. 1988. PMID: 3416086 French.

2

[Pharmacokinetic study of active ultrafiltrable platinum during a 5-day course of continuous constant flow infusion of cisplatin with modification of the dosage].

Dechamp C, Rinaldi Y, Durand A, Favre R. Dechamp C, et al. Among authors: favre r. Bull Cancer. 1989;76(8):883-5. Bull Cancer. 1989. PMID: 2620117 French. No abstract available.

3

Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.

Lena N, Imbert AM, Favre R, Cano JP, Carcassonne Y. Lena N, et al. Among authors: favre r. Eur J Cancer Clin Oncol. 1987 May;23(5):481-5. doi: 10.1016/0277-5379(87)90307-5. Eur J Cancer Clin Oncol. 1987. PMID: 3477455

4

Methotrexate and 7-hydroxy-methotrexate pharmacokinetics following intravenous bolus administration and high-dose infusion of methotrexate.

Bore P, Bruno R, Lena N, Favre R, Cano JP. Bore P, et al. Among authors: favre r. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1385-90. doi: 10.1016/0277-5379(87)90124-6. Eur J Cancer Clin Oncol. 1987. PMID: 3500051 Clinical Trial.

5

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).

Rahmani R, Bruno R, Iliadis A, Favre R, Just S, Barbet J, Cano JP. Rahmani R, et al. Among authors: favre r. Cancer Res. 1987 Nov 1;47(21):5796-9. Cancer Res. 1987. PMID: 3664483

6

Assay of methotrexate and 7-hydroxymethotrexate by gradient-elution high-performance liquid chromatography and its application in a high-dose pharmacokinetic study.

Fabre G, Cano JP, Iliadis A, Carcassonne Y, Favre R, Gilli R, Catalin J. Fabre G, et al. Among authors: favre r. J Pharm Biomed Anal. 1984;2(1):61-72. doi: 10.1016/0731-7085(84)80090-4. J Pharm Biomed Anal. 1984. PMID: 16867766

7

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.

Dupuis C, Mercier C, Yang C, Monjanel-Mouterde S, Ciccolini J, Fanciullino R, Pourroy B, Deville JL, Duffaud F, Bagarry-Liegey D, Durand A, Iliadis A, Favre R. Dupuis C, et al. Among authors: favre r. Anticancer Drugs. 2008 Mar;19(3):267-73. doi: 10.1097/cad.0b013e3282f21376. Anticancer Drugs. 2008. PMID: 18510172

8

High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach.

Monjanel S, Rigault JP, Cano JP, Carcassonne Y, Favre R. Monjanel S, et al. Among authors: favre r. Cancer Chemother Pharmacol. 1979;3(3):189-96. doi: 10.1007/BF00262421. Cancer Chemother Pharmacol. 1979. PMID: 527209

9

Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocol.

Cano JP, Bruno R, Lena N, Favre R, Iliadis A, Imbert AM. Cano JP, et al. Among authors: favre r. Cancer Drug Deliv. 1985 Fall;2(4):271-6. doi: 10.1089/cdd.1985.2.271. Cancer Drug Deliv. 1985. PMID: 3864520

10

Dosage predictions in high-dose methotrexate infusions. Part 2: Bayesian estimation of methotrexate clearance.

Bruno R, Iliadis A, Favre R, Lena N, Imbert AM, Cano JP. Bruno R, et al. Among authors: favre r. Cancer Drug Deliv. 1985 Fall;2(4):277-83. doi: 10.1089/cdd.1985.2.277. Cancer Drug Deliv. 1985. PMID: 4063950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters